Navigation Links
Regeneron Reports Fourth Quarter and Full Year 2012 Financial and Operating Results
Date:2/14/2013

nited States, and share profits and losses from commercialization of EYLEA outside the United States except for Japan, where the Company receives a royalty on sales.  Regeneron maintains exclusive rights to EYLEA in the United States and is entitled to all profits from any such sales.
  • In November 2012, Bayer HealthCare received regulatory approval for EYLEA in the European Union for the treatment of patients with wet AMD.  In November 2012, Bayer HealthCare received pricing approval for EYLEA in Japan for the treatment of patients with wet AMD. 
  • Net sales recorded by Bayer HealthCare for EYLEA outside of the United States were $19 million in the fourth quarter of 2012.
  • Launches in additional countries are anticipated to continue throughout 2013 as regulatory and pricing approvals are achieved.
  • Bayer HealthCare submitted applications for marketing authorization for EYLEA in Europe in December 2012 and in Japan in January 2013 for the treatment of macular edema following CRVO.
  • ZALTRAP® (ziv-aflibercept) Injection for Intravenous Infusion

  • The Company and Sanofi collaborate on the global development and commercialization of ZALTRAP, and share profits and losses from commercialization of ZALTRAP except for Japan, where the Company receives a royalty on sales.  Sales of ZALTRAP in the United States commenced in August 2012, and net sales recorded by Sanofi were $23 million in the fourth quarter and $32 million for the full year of 2012.
  • In February 2013, the European Commission (EC) granted marketing authorization in the European Union for ZALTRAP concentrate for solution for infusion in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) chemotherapy in adults with metastatic colorectal cancer (mCRC) that is resistant to or has progressed after an oxaliplatin-containing regimen.  
  • Marketing authorization applications for ZALTRAP are current
    '/>"/>

  • SOURCE Regeneron Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. Regeneron Announces Receipt of Hart-Scott-Rodino Notice
    2. Regeneron to Report Fourth Quarter and Full Year 2012 Financial and Operating Results and Host Conference Call and Webcast on February 14, 2013
    3. Regeneron Announces Presentation at the Deutsche Bank 2012 dbAccess BioFEST
    4. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
    5. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
    6. BioMed Realty Announces 80,500 Square Foot Lease Expansion For Regeneron Pharmaceuticals
    7. Regeneron Named Worlds #1 Biopharmaceutical Employer in Science Magazine Annual Survey
    8. Regeneron Announces September 2012 Investor Conference Presentations
    9. Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012
    10. Regeneron Announces June 2012 Investor Conference Presentations
    11. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/20/2014)... Norgine B.V. today announced that ... bowel preparation, NER1006, presented at the 79 th ... (ACG), Philadelphia, PA , has met ... co-primary endpoint of cleansing success. The study demonstrated high ... in screening colonoscopy patients. [1] ...
    (Date:10/19/2014)... 19, 2014 Große Pharmafirmen ... Das Problem dabei ist, dass große Pharmafirmen nicht ... zu teilen. Es war deshalb nicht ... uns umso mehr, dass es uns gelungen ist! ... Kühlketten aufzuschreiben - mit einem Vorbehalt - einige ...
    (Date:10/17/2014)... OAKS, Calif. , Oct. 17, 2014  Amgen ... of R. Sanders Williams , M.D., president of ... Mahley Distinguished Professor.  "We are pleased ... Amgen Board," said Robert A. Bradway , chairman ... and distinguished experience in academic medicine and his direct ...
    Breaking Medicine Technology:Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 2Vergleichsbericht zu Pharma-Kühlketten und CRT 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 3
    (Date:10/20/2014)... Fort Collins, CO (PRWEB) October 20, 2014 ... platform, dGH assays are the only imaging assays ... data in a single test.  With these three ... in their ability to detect the widest range ... chromosomal translocations—mutations usually missed by other genomic tools, ...
    (Date:10/20/2014)... 2014 Unveiled at the Sept. 18 board ... conservatively estimates member hospital ROI on membership dues at 12.5. ... Center provides $12.50 in value to member hospitals. The calculation ... Member Dues)/Member Dues. , “This is the first time ... we think the methodology is really sound,” said Bill ...
    (Date:10/20/2014)... October 20, 2014 Houston plastic surgeon ... the key elements of his innovative True Form ... plastic surgery residents and faculty at The University ... he, too, was once a medical student. Patronella, who ... private cosmetic plastic surgery practices in Texas, The ...
    (Date:10/19/2014)... The leading review website, Top10BestSEOHosting.com, ... and GreenGeeks are the best Dedicated Server Hosting ... who want to buy high quality hosting and ... IT manager of Top10BestSEOHosting.com says, “We believe that ... for everyone. A lot of the global clients ...
    (Date:10/19/2014)... (PRWEB) October 20, 2014 This ... for Partial Seizure, complete with comparative analysis at ... of action (MoA), route of administration (RoA) and ... news and press releases. It also reviews key ... Seizure and special features on late-stage and discontinued ...
    Breaking Medicine News(10 mins):Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4
    ... Ont., July 20, 2010--Most studies of healthcare for homeless people ... surprising that lack of money and insurance are the main ... have publicly funded universal health care? A new study ... _one in six _ reported unmet health care needs. ...
    ... 20, 2010) -- Chaos models may someday help model cardiac ... in the journal CHAOS, which is published by ... has drawn more attention to chaos in cardiac dynamics. Although ... origin of chaos and watching it develop might allow researchers ...
    ... WEDNESDAY, July 21 (HealthDay News) -- A two-step procedure that ... then inserts stem cells to promote healing of those arteries ... "One of the problems of removing plaque [with current ... the underlying wall," explained Dr. Edward A. Fisher, director of ...
    ... Most people know that high cholesterol levels place them at ... has shown that particular types of strokes contribute to one,s ... increase the risk of depression in the elderly. ... Biological Psychiatry , suggest the link between increased cholesterol and ...
    ... the journal Development , by Dr. Anthony-Samuel LaMantia, ... newly formed GW Institute for Neuroscience, and his colleagues ... classes of nerve cells olfactory receptors (ORNs), vomeronasal ... are responsible for enabling animals and humans, to eat, ...
    ... if an emergency room patient wants a different doctor than ... the patient is a woman or a racial minority, emergency ... a doctor of their same gender, race or religious background. ... System, along with colleagues from the University of Rochester and ...
    Cached Medicine News:Health News:Toronto homeless report barriers to health care 2Health News:Procedure Rejuvenates Aging Arteries in Pigs 2Health News:Procedure Rejuvenates Aging Arteries in Pigs 3Health News:New links between cholesterol and depression in the elderly 2Health News:Researchers pinpoint key stem cells for eating and sex 2Health News:Women, minorities more likely to see doctor of choice in emergency room 2
    Mini ReadySub-Cell GT Cell, includes buffer tank, lid and electrodes, leveling bubble; accommodates 8-well and 12-well mini ReadyAgarose gels...
    The Large Gel Drying Kit dries gels using the same principal components as the DryEase Mini-Gel Drying System but can accommodate larger format gels or four mini-gels. A base is not required for asse...
    ... Preserve your data for future generations. Most ... the solid backing plate of our gel dryer, ... a frame over them to hold the cellophane ... a frame with an open area somewhat larger ...
    ... for future generations. Most gels can be dried ... of our gel dryer, covering them with wet ... to hold the cellophane flat. Tut's Tombs also ... open area somewhat larger than the gel to ...
    Medicine Products: